Literature DB >> 19276544

Implication of GAB2 gene polymorphism in Italian patients with Alzheimer's disease.

Benedetta Nacmias1, Andrea Tedde, Silvia Bagnoli, Elena Cellini, Bianca Maria Guarnieri, Silvia Piacentini, Sandro Sorbi.   

Abstract

A common polymorphism (rs2373115) in the GRB-associated binding protein 2 (GAB2) gene has been recently associated with the risk of developing Alzheimer's disease (AD) in 644 apolipoprotein E (ApoE) epsilon4 carriers. In order to assess the involvement of the GAB2 polymorphism in the risk of developing AD, we analyzed the genotype and allele distributions of the GAB2 rs2373115 polymorphism in 579 Italian subjects. Our results support a possible implication of GAB2 genetic variant in AD. However, the observed association was confined to ApoE epsilon4 non-carriers, thus suggesting a possible role of GAB2 as an independent risk factor for AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276544     DOI: 10.3233/JAD-2009-1005

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  11 in total

Review 1.  The Gab2 in signal transduction and its potential role in the pathogenesis of Alzheimer's disease.

Authors:  Xiao-Ling Pan; Ru-Jing Ren; Gang Wang; Hui-Dong Tang; Sheng-Di Chen
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

2.  Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriers.

Authors:  Winnie S Liang; Kewei Chen; Wendy Lee; Kunal Sidhar; Jason J Corneveaux; April N Allen; Amanda Myers; Stephen Villa; Bessie Meechoovet; Jeremy Pruzin; Daniel Bandy; Adam S Fleisher; Jessica B S Langbaum; Matthew J Huentelman; Kendall Jensen; Travis Dunckley; Richard J Caselli; Susan Kaib; Eric M Reiman
Journal:  Neuroimage       Date:  2010-10-01       Impact factor: 6.556

3.  Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels.

Authors:  John S K Kauwe; Carlos Cruchaga; Sarah Bertelsen; Kevin Mayo; Wayne Latu; Petra Nowotny; Anthony L Hinrichs; Anne M Fagan; David M Holtzman; Alison M Goate
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1.

Authors:  Ziran Wang; Hongyan Lei; Mei Zheng; Yuxin Li; Yansen Cui; Fang Hao
Journal:  Mol Neurobiol       Date:  2015-11-27       Impact factor: 5.590

5.  Function, regulation and pathological roles of the Gab/DOS docking proteins.

Authors:  Franziska U Wöhrle; Roger J Daly; Tilman Brummer
Journal:  Cell Commun Signal       Date:  2009-09-08       Impact factor: 5.712

6.  GAB2 is not associated with late-onset Alzheimer's disease in Chinese Han.

Authors:  Kangguang Lin; Muni Tang; Haiying Han; Yangbo Guo; Yuhua Lin; Cui Ma
Journal:  Neurol Sci       Date:  2009-11-19       Impact factor: 3.307

7.  Meta-analysis of association between the genetic polymorphisms on chromosome 11q and Alzheimer's disease susceptibility.

Authors:  Weidong Ji; Lanling Xu; Haiyun Zhou; Suishan Wang; Yan Fang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  The impact of GAB2 genetic variations on cerebrospinal fluid markers in Alzheimer's disease.

Authors:  Xiao-Xiao Chen; Run-Rong Guo; Xi-Peng Cao; Lin Tan; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

9.  Linking protective GAB2 variants, increased cortical GAB2 expression and decreased Alzheimer's disease pathology.

Authors:  Fanggeng Zou; Olivia Belbin; Minerva M Carrasquillo; Oliver J Culley; Talisha A Hunter; Li Ma; Gina D Bisceglio; Mariet Allen; Dennis W Dickson; Neill R Graff-Radford; Ronald C Petersen; Kevin Morgan; Steven G Younkin
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

10.  Association of HLA-DRB1 polymorphism with Alzheimer's disease: a replication and meta-analysis.

Authors:  Rui-Chun Lu; Wu Yang; Lin Tan; Fu-Rong Sun; Meng-Shan Tan; Wei Zhang; Hui-Fu Wang; Lan Tan
Journal:  Oncotarget       Date:  2017-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.